$ACT News Intuitive Surgical slumps; Facebook extends

New Post Public Reply Private Reply Replies (0) Message Board

Apr 11, 2014 at 8:51 PM

$ACT News

Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - blogs.marketwatch.com
Mylan to start selling generic Celebrex in May 7:22 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter 4:09 p.m. March 6, 2014 - Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 11:12 a.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com

Acura Pharma Ends Agreement with Pfizer - Analyst Blog 5:35 p.m. Today - Zacks.com
Facebook, Arris, Grifols Initiate New Bases 5:35 p.m. Today - Investors Business Daily
3 Health Care Stocks Moving The Sector Upward 1:02 p.m. Today - TheStreet.com
Regulatory Update from Forest Labs - Analyst Blog 4:40 p.m. April 10, 2014 - Zacks.com
Actavis Becomes #157 Most Shorted S&P 500 Component, Replacing Vornado Realty Trust 3:19 p.m. April 10, 2014 - TheStreet.com
Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick 12:27 a.m. April 10, 2014 - Seeking Alpha
Mallinckrodt plc (MNK) in Focus: Stock Moves 5.3% Higher - Tale of the Tape 8:37 a.m. April 9, 2014 - Zacks.com
Alexion, Biogen Among Leading Big-Cap Biotechs 7:02 a.m. April 9, 2014 - Investors Business Daily
Pacira and Patheon Collaborate - Analyst Blog 6:10 p.m. April 8, 2014 - Zacks.com
Additional Data on Pacira's Exparel - Analyst Blog 5:20 p.m. April 8, 2014 - Zacks.com
Should You Get Rid of Relypsa (RLYP) Now? - Tale of the Tape 8:44 a.m. April 7, 2014 - Zacks.com
Actavis PLC (ACT): Today's Featured Drugs Laggard 5:01 p.m. April 4, 2014 - TheStreet.com
Caesarstone, Other Leading Stocks Showing Supporting Action 4:49 p.m. April 4, 2014 - Investors Business Daily
Mylan Bid Gets Rejected, But Generic-Drugmaker Rises 4:28 p.m. April 4, 2014 - Investors Business Daily
3 Stocks Dragging The Drugs Industry Downward 1:02 p.m. April 4, 2014 - TheStreet.com
Mylan Rejected In Bid To Acquire Sweden's Meda 11:27 a.m. April 4, 2014 - Investors Business Daily
Mylan Eyes Swedish Drug Maker 10:12 p.m. April 3, 2014 - The Wall Street Journal Interactive Edition
Actavis Up Slightly on Silom Acquisition - Analyst Blog 3:56 p.m. April 3, 2014 - Zacks.com
Four Top World Stocks Offer Follow-On Buy Points 5:11 p.m. April 2, 2014 - Investors Business Daily
Pacira Up as Exparel Site Gets FDA Nod - Analyst Blog 6:00 p.m. April 1, 2014 - Zacks.com

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. Today - PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines 12:30 p.m. April 10, 2014 - PR Newswire - PRF
Actavis Launches Asia Pacific Regional Headquarters in Singapore 8:00 p.m. April 2, 2014 - PR Newswire - PRF
Particle Sciences and Actavis Enter into Joint Development Agreement 11:00 a.m. April 1, 2014 - PR Newswire - PRF
Actavis Acquires Silom Medical Company 8:30 a.m. April 1, 2014 - PR Newswire - PRF
Actavis Completes Divestiture of Commercial Operations in Seven Western European Countries to Aurobindo Pharma Limited 8:00 a.m. April 1, 2014 - PR Newswire - PRF
Actavis Confirms Favorable Ruling in Generic Lialda® Patent Suit 4:05 p.m. March 28, 2014 - PR Newswire - PRF
Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3% 5:00 p.m. March 25, 2014 - PR Newswire - PRF
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3% 5:00 p.m. March 25, 2014 - PR Newswire - PRF
Actavis to Host First Quarter 2014 Earnings Conference Call and Webcast 4:33 p.m. March 21, 2014 - PR Newswire - PRF
Pharmaceutical Equities under Review -- Research on Zoetis, Mylan, AVANIR Pharma and Actavis 11:11 a.m. March 21, 2014 - PR Newswire - PRF
Actavis Announces Daytrana® Patent Challenge Settlement 4:05 p.m. March 19, 2014 - PR Newswire - PRF
New Drug Applications, Earnings Release Schedules, Drug Designations, New Services, and Clinical Trials - Analyst Notes on Actavis, Intercept, GW Pharmaceuticals, Galena, and Conatus 8:00 a.m. March 13, 2014 - PR Newswire - PRF
Actavis Confirms Favorable Ruling in Generic Celebrex® Patent Suit 5:35 p.m. March 12, 2014 - PR Newswire - PRF
Columbia Laboratories Repurchases 1.4 Million Shares of Common Stock from Actavis 6:50 a.m. March 7, 2014 - PR Newswire - PRF
Actavis to Present at Barclays Global Healthcare Conference 8:00 a.m. March 4, 2014 - PR Newswire - PRF
Actavis Confirms Generic Colcrys® Patent Challenge 4:05 p.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Confirms Generic Multaq® Patent Challenge 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

B2B Growth Hinges on Narrative Coherence, Study Shows

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

American Savings Bank IPO Hits NYSE: $129M Raised

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Finastra Recognized as 2026 Leader in Payment Platforms

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

OrthoAtlanta Expands with Dr. Smith's Expertise Hire

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Solar Fencing Revolutionizes North Texas Homes

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Lyric Health's AI System Promises Data-Driven Revolution

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Ransoms and Mega-Losses Surge in Cyber Claims Study

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

ScholarShare 529 Launches $50 Back-to-School Promo

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Koogler's Sale to ALL4: A Game-Changer for the Southeast

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Red Banyan Earns Top Honors in Florida for 2026

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...